Condition
Middle Cerebral Artery Infarction
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
Early P 1 (1)
P 2 (3)
Trial Status
Completed3
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02609256Not ApplicableTerminatedPrimary
Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery
NCT02425670Phase 2CompletedPrimary
Stem Cell Therapy For Acute Ischemic Stroke Patients
NCT01461720Phase 2UnknownPrimary
Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
NCT00950521Phase 2Completed
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
NCT00612300Early Phase 1Completed
Gait Training for Persons With Stroke
Showing all 5 trials